- emergers.se - Page 4

NANEXA: Progress with NEX-20 and NEX-22 Amid Rising GLP-1 Interest

2023-08-24• Analys, Research

Nanexa’s Q2’23 advancements with NEX-20 and NEX-22 underscore the company’s forward momentum. NEX-20 is set to provide a more...

Read More →

KEBNI: Financing and second volume order clear path for sales surge in 2023-2026

2023-08-10• Analys, Research

Late Wednesday evening KebNi announced that it has raised SEK 29.6m from a group of professional investors, including the two largest of...

Read More →

BONZUN: Merger with L2S a favorable reconfiguration for Bonzun’s shareholders

2023-07-07• Research

Bonzun has agreed to sell all shares in its subsidiary Bonzun Evolve to CBT-based sleep therapy company Learning to Sleep (L2S, listed on...

Read More →

GRANGEX: Final regulatory hurdle cleared to materialise the world’s first CO2-free iron ore mine

2023-06-26• Analys, Research

GRÄNGESBERG EXPLORATION The Land and Environmental Court has now granted GRANGEX the permit for mining operations at Dannemora, meaning...

Read More →

BONZUN: Q1 growth and deal momentum affirm the growth story emerging in Bonzun

2023-06-01• Research

While still modest in absolute terms, the Q1 sales growth and deals year-to-date signed affirm the growth story we see emerging in Bonzun,...

Read More →

QLUCORE: Delayed CE approval suggests upcoming need for additional financing

2023-06-01• Analys, Research

With BSI as Notified Body, Qlucore now expects to obtain CE certification for its Qlucore Diagnostics ALL application in February 2025....

Read More →

KEBNI: Broad support for long-term revenue target but cash an increasing concern

2023-05-24• Analys, Research

KebNi reported an 80% revenue growth in Q1’23, to SEK 10.9m, largely due to sales of satellite antennas to IAI. Despite a variety of...

Read More →

NANEXA: Solid progress in development into 2023, with funding needs on the horizon

2023-05-05• Analys, Research

After positive pre-clinical results in rats with NEX-22 (for treatment of type 2 diabetes) in Q1, we now see results from phase I for...

Read More →

BONZUN: Six deals to date validate scale-up with municipalities for DTx service Evolve

2023-04-18• Research

On the back of the framework agreement with the Swedish Security Council (TRR) for Bonzun’s digital CBT service Evolve signed in Q4’22,...

Read More →

CAPSEK: Övertecknad emission i CapSeks Klash Studio

2023-03-31• Okategoriserade

CapSeks portföljbolag Klash Studio fullbordade nyligen en emission med deltagande från CapSek samt flera namnkunniga investerare med...

Read More →

Författare: johan@emergers.se

NANEXA: Progress with NEX-20 and NEX-22 Amid Rising GLP-1 Interest

KEBNI: Financing and second volume order clear path for sales surge in 2023-2026

BONZUN: Merger with L2S a favorable reconfiguration for Bonzun’s shareholders

GRANGEX: Final regulatory hurdle cleared to materialise the world’s first CO2-free iron ore mine

BONZUN: Q1 growth and deal momentum affirm the growth story emerging in Bonzun

QLUCORE: Delayed CE approval suggests upcoming need for additional financing

KEBNI: Broad support for long-term revenue target but cash an increasing concern

NANEXA: Solid progress in development into 2023, with funding needs on the horizon

BONZUN: Six deals to date validate scale-up with municipalities for DTx service Evolve

CAPSEK: Övertecknad emission i CapSeks Klash Studio

Widmark Research

CONTACT